Clinical Trial Update: Optical Coherence Tomography Following Paclitaxel Eluting Stent Implantation in Multivessel Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing optical coherence tomography after paclitaxel-eluting stent implantation in multivessel coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: A.O. Ospedale Papa Giovanni XXIII | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED